BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Latest reported BGLC revenue for 2026-06-30 was $99.0K. Net income was -$830.0K. BGLC currently screens at market cap $6.1M.
Use this BGLC page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BGLC quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BGLC SEC filings page. Lician reads the product cache first so this HTML stays unique to BioNexus Gene Lab Corp Common stock even when a live quote feed is slow.
Latest cached year on this hub. Full BGLC income, balance, and cash tables.